Synonyms: AMYViD® | AV-45 | florbetapir (18F)
florbetapir is an approved drug (FDA (2012), EMA (2013))
Compound class:
Synthetic organic
Comment: Florbetapir F18 is a molecular imaging agent (diagnostic radiopharmaceutical) that binds to β-amyloid aggregates in Alzheimer's brains.
|
|
References |
1. Cortes-Blanco A, Prieto-Yerro C, Martinez-Lazaro R, Zamora J, Jiménez-Huete A, Haberkamp M, Pohly J, Enzmann H, Zinserling J, Strassmann V et al.. (2014)
Florbetapir (18F) for brain amyloid positron emission tomography: highlights on the European marketing approval. Alzheimers Dement, 10 (5 Suppl): S395-9. [PMID:24418060] |
2. Yu P, Cui M, Wang X, Zhang X, Li Z, Yang Y, Jia J, Zhang J, Ono M, Saji H et al.. (2012)
¹⁸F-labeled 2-phenylquinoxaline derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques. Eur J Med Chem, 57: 51-8. [PMID:23047223] |